Fennec Pharmaceuticals (FENC) Payables (2016 - 2025)
Historic Payables for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $5.9 million.
- Fennec Pharmaceuticals' Payables rose 5169.38% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 5169.38%. This contributed to the annual value of $3.2 million for FY2024, which is 1421.39% down from last year.
- Fennec Pharmaceuticals' Payables amounted to $5.9 million in Q3 2025, which was up 5169.38% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' Payables ranged from a high of $5.9 million in Q2 2025 and a low of $677000.0 during Q2 2021
- In the last 5 years, Fennec Pharmaceuticals' Payables had a median value of $3.0 million in 2023 and averaged $3.3 million.
- Its Payables has fluctuated over the past 5 years, first plummeted by 7542.65% in 2021, then surged by 15745.94% in 2022.
- Fennec Pharmaceuticals' Payables (Quarter) stood at $1.2 million in 2021, then soared by 107.11% to $2.4 million in 2022, then skyrocketed by 58.08% to $3.8 million in 2023, then decreased by 14.21% to $3.2 million in 2024, then surged by 80.99% to $5.9 million in 2025.
- Its Payables stands at $5.9 million for Q3 2025, versus $5.9 million for Q2 2025 and $5.3 million for Q1 2025.